Related Experiment Videos

Expression of streptococcal M protein in mammalian cells

D E Hruby1, W M Hodges, E M Wilson

  • 1Department of Microbiology, Oregon State University, Corvallis 97331.

Insights

Group A Streptococcus M protein aids bacterial evasion. A vaccinia virus recombinant (VV:M6 delta) expressing M protein shows promise as a vaccine candidate for preventing streptococcal diseases.

Area of Science:

  • Microbiology
  • Immunology
  • Vaccinology

Background:

  • Group A Streptococcus (GAS) causes various diseases.
  • The GAS M protein is crucial for immune evasion and pathogenesis.
  • Developing effective vaccines against GAS is a public health priority.

Purpose of the Study:

  • To construct a recombinant vaccinia virus expressing the M protein gene.
  • To assess the stability and expression of the M protein gene in the viral vector.
  • To evaluate the potential of this recombinant as a vaccine candidate.

Main Methods:

  • Gene construction: M protein gene inserted into vaccinia virus.
  • Stability assessment: Bacterial DNA sequence stability within the viral genome.
  • Expression analysis: Detection of M protein in infected mammalian cells.

Main Results:

  • The M protein DNA sequence was stable in the vaccinia virus recombinant (VV:M6 delta).
  • The M protein gene was actively transcribed by viral RNA polymerase.
  • Immunoreactive M protein was detected in vivo in infected cells.

Conclusions:

  • The VV:M6 delta recombinant provides a tool for studying M protein immunodominant domains.
  • This recombinant shows potential as a vaccine candidate for animal trials.
  • Further research may lead to novel strategies for combating streptococcal infections.

Related Concept Videos